This webpage contains legacy information. The product is either no longer available from the supplier or has been delisted at Labome.
product summary
company name :
EMD Millipore
other brands :
Oncogene Research Products, Calbiochem, Novagen, Merck, Upstate Biotechnology, Chemicon, LINCO, Novabiochem, Guava
product type :
antibody
product name :
hHUMMR Antibody
catalog :
ABN24
quantity :
100 μg
clonality :
polyclonal
host :
domestic rabbit
conjugate :
nonconjugated
reactivity :
human
application :
western blot, immunocytochemistry
product information
Catalog Number :
ABN24
Subcategory :
Neuroscience
Product Name :
Anti-hHUMMR Antibody
Product Type :
Antibodies
Clonality :
Polyclonal Antibody
Gene ID :
Q8TDB4
Host Name :
Rabbit
Antigen :
hHUMMR
Conjugate :
Affinity Purified
Product Description :
Anti-hHUMMR Antibody
Cross Reactivity :
Human
Background :
Hypoxia up-regulated mitochondrial movement regulator (HUMMR), a novel mitochondria protein, is expressed in neurons and is markedly induced by hypoxia-inducible factor 1 α (HIF-1α). HUMMR interacts with Miro-1 and Miro-2, mitochondrial proteins that are critical for mediating mitochondrial transport. Knockdown of HUMMR or HIF-1 function in neurons exposed to hypoxia markedly reduces mitochondrial content in axons.
ALT Names :
Hypoxia up-regulated mitochondrial movement regulator
Immunogen :
KLH-conjugated linear peptide corresponding to human HUMMR.
Specificity :
This antibody recognizes a novel human HUMMR protein.
Package Size :
100 μg
Uses :
Western Blotting;Immunocytochemistry
Storage :
Stable for 1 year at 2-8°C from date of receipt
company information
EMD Millipore
290 Concord Road
Billerica, Massachusetts 01821
Billerica, Massachusetts 01821
bioscienceshelp@emdchemical.com
https://www.emdmillipore.com888-854-3417
headquarters: United States
EMD Millipore is the Life Science division of Merck KGaA of Darmstadt, Germany
Hundreds of New Antibodies in the areas of:
View all the new antibodies at www.emdmillipore.com.
Hundreds of New Antibodies in the areas of:
|
|
questions and comments
